{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:20:27Z","timestamp":1768209627844,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"DOI":"10.7759\/cureus.94202","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:42:42Z","timestamp":1760017362000},"source":"Crossref","is-referenced-by-count":2,"title":["Rituximab-Induced Acute Coronary Syndrome"],"prefix":"10.7759","author":[{"given":"Paschal  O","family":"Ndukwu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niharika","family":"Patlolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neharika","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Mohsin","family":"Isar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Rituximab-induced acute ST elevation myocardial infarction","volume":"15","author":"Keswani AN","year":"2015","unstructured":"Keswani AN, Williams C, Fuloria J, Polin NM, Jahangir E. Rituximab-induced acute ST elevation myocardial infarction. Ochsner J. 2015, 15:187-90.","journal-title":"Ochsner J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-12-2853","article-title":"Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock","volume":"41","author":"Roy A","year":"2014","unstructured":"Roy A, Khanna N, Senguttuvan NB. Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock. Tex Heart Inst J. 2014, 41:80-2. 10.14503\/THIJ-12-2853","journal-title":"Tex Heart Inst J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.87003","article-title":"Rituximab induced myocardial infarction: a fatal drug reaction","volume":"7","author":"Arunprasath P","year":"2011","unstructured":"Arunprasath P, Gobu P, Dubashi B, Satheesh S, Balachander J. Rituximab induced myocardial infarction: a fatal drug reaction. J Cancer Res Ther. 2011, 7:346-8. 10.4103\/0973-1482.87003","journal-title":"J Cancer Res Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202302259RR","article-title":"Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases","volume":"38","author":"Mostkowska A","year":"2024","unstructured":"Mostkowska A, Rousseau G, Raynal NJ. Repurposing of rituximab biosimilars to treat B cell mediated autoimmune diseases. FASEB J. 2024, 38:e23536. 10.1096\/fj.202302259RR","journal-title":"FASEB J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/HPC.0b013e3182315a85","article-title":"Can the HEART score safely reduce stress testing and cardiac imaging in patients at low risk for major adverse cardiac events?","volume":"10","author":"Mahler SA","year":"2011","unstructured":"Mahler SA, Hiestand BC, Goff DC Jr, Hoekstra JW, Miller CD. Can the HEART score safely reduce stress testing and cardiac imaging in patients at low risk for major adverse cardiac events?. Crit Pathw Cardiol. 2011, 10:128-33. 10.1097\/HPC.0b013e3182315a85","journal-title":"Crit Pathw Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/acem.13649","article-title":"Prognostic accuracy of the HEART score for prediction of major adverse cardiac events in patients presenting with chest pain: a systematic review and meta-analysis","volume":"26","author":"Fernando SM","year":"2019","unstructured":"Fernando SM, Tran A, Cheng W, et al.. Prognostic accuracy of the HEART score for prediction of major adverse cardiac events in patients presenting with chest pain: a systematic review and meta-analysis. Acad Emerg Med. 2019, 26:140-51. 10.1111\/acem.13649","journal-title":"Acad Emerg Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2008.n.035","article-title":"Acute coronary syndromes complicating the first infusion of rituximab","volume":"8","author":"Armitage JD","year":"2008","unstructured":"Armitage JD, Montero C, Benner A, Armitage JO, Bociek G. Acute coronary syndromes complicating the first infusion of rituximab. Clin Lymphoma Myeloma. 2008, 8:253-5. 10.3816\/CLM.2008.n.035","journal-title":"Clin Lymphoma Myeloma"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/984986","article-title":"Rituximab-induced coronary vasospasm","volume":"2012","author":"Lee L","year":"2012","unstructured":"Lee L, Kukreti V. Rituximab-induced coronary vasospasm. Case Rep Hematol. 2012, 2012:984986. 10.1155\/2012\/984986","journal-title":"Case Rep Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15171\/jrip.2017.04","article-title":"Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy","volume":"6","author":"Cheungpasitporn W","year":"2017","unstructured":"Cheungpasitporn W, Kopecky SL, Specks U, Bharucha K, Fervenza FC. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy. J Renal Inj Prev. 2017, 6:18-25. 10.15171\/jrip.2017.04","journal-title":"J Renal Inj Prev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/ijdd.ijdd_64_19","article-title":"Cardiac side effect of rituximab","volume":"6","author":"Patil VB","year":"2020","unstructured":"Patil VB, Lunge SB, Doshi BR. Cardiac side effect of rituximab. Indian J Drugs Dermatol. 2020, 6:49-52. 10.4103\/ijdd.ijdd_64_19","journal-title":"Indian J Drugs Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.03.003","article-title":"Cardiac side-effects of cancer chemotherapy","volume":"144","author":"Monsuez JJ","year":"2010","unstructured":"Monsuez JJ, Charniot JC, Vignat N, Artigou JY. Cardiac side-effects of cancer chemotherapy. Int J Cardiol. 2010, 144:3-15. 10.1016\/j.ijcard.2010.03.003","journal-title":"Int J Cardiol"},{"key":"ref12","article-title":"Monoclonal antibodies in the treatment of cancer, part 2","volume":"60","author":"Cersosimo RJ","year":"2003","unstructured":"Cersosimo RJ. Monoclonal antibodies in the treatment of cancer, part 2. Am J Health Syst Pharm. 2003, 60:1631-41; quiz 1642-3.","journal-title":"Am J Health Syst Pharm"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2015.10.374","article-title":"Updated cardiac concerns with rituximab use: a growing challenge","volume":"68 Suppl 2","author":"Verma SK","year":"2016","unstructured":"Verma SK. Updated cardiac concerns with rituximab use: a growing challenge. Indian Heart J. 2016, 68 Suppl 2:S246-8. 10.1016\/j.ihj.2015.10.374","journal-title":"Indian Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/390842-rituximab-induced-acute-coronary-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:42:42Z","timestamp":1760017362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/390842-rituximab-induced-acute-coronary-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.94202","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}